Form 8-K - Current report:
SEC Accession No. 0001193125-24-171204
Filing Date
2024-06-28
Accepted
2024-06-28 06:46:32
Documents
46
Period of Report
2024-06-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d860381d8k.htm   iXBRL 8-K 29984
2 EX-99.1 d860381dex991.htm EX-99.1 42431
6 GRAPHIC g860381ex99_1s10g1.jpg GRAPHIC 97922
7 GRAPHIC g860381ex99_1s11g1.jpg GRAPHIC 95225
8 GRAPHIC g860381ex99_1s12g1.jpg GRAPHIC 95890
9 GRAPHIC g860381ex99_1s13g1.jpg GRAPHIC 136147
10 GRAPHIC g860381ex99_1s14g1.jpg GRAPHIC 114220
11 GRAPHIC g860381ex99_1s15g1.jpg GRAPHIC 49235
12 GRAPHIC g860381ex99_1s16g1.jpg GRAPHIC 108903
13 GRAPHIC g860381ex99_1s17g1.jpg GRAPHIC 105274
14 GRAPHIC g860381ex99_1s18g1.jpg GRAPHIC 87179
15 GRAPHIC g860381ex99_1s19g1.jpg GRAPHIC 73963
16 GRAPHIC g860381ex99_1s1g1.jpg GRAPHIC 71139
17 GRAPHIC g860381ex99_1s20g1.jpg GRAPHIC 88352
18 GRAPHIC g860381ex99_1s21g1.jpg GRAPHIC 73068
19 GRAPHIC g860381ex99_1s22g1.jpg GRAPHIC 61030
20 GRAPHIC g860381ex99_1s23g1.jpg GRAPHIC 88936
21 GRAPHIC g860381ex99_1s24g1.jpg GRAPHIC 128593
22 GRAPHIC g860381ex99_1s25g1.jpg GRAPHIC 122573
23 GRAPHIC g860381ex99_1s26g1.jpg GRAPHIC 86120
24 GRAPHIC g860381ex99_1s27g1.jpg GRAPHIC 88298
25 GRAPHIC g860381ex99_1s28g1.jpg GRAPHIC 111901
26 GRAPHIC g860381ex99_1s29g1.jpg GRAPHIC 131920
27 GRAPHIC g860381ex99_1s2g1.jpg GRAPHIC 197869
28 GRAPHIC g860381ex99_1s30g1.jpg GRAPHIC 60907
29 GRAPHIC g860381ex99_1s31g1.jpg GRAPHIC 145351
30 GRAPHIC g860381ex99_1s32g1.jpg GRAPHIC 64452
31 GRAPHIC g860381ex99_1s3g1.jpg GRAPHIC 119444
32 GRAPHIC g860381ex99_1s4g1.jpg GRAPHIC 119014
33 GRAPHIC g860381ex99_1s5g1.jpg GRAPHIC 107571
34 GRAPHIC g860381ex99_1s6g1.jpg GRAPHIC 132286
35 GRAPHIC g860381ex99_1s7g1.jpg GRAPHIC 120905
36 GRAPHIC g860381ex99_1s8g1.jpg GRAPHIC 138223
37 GRAPHIC g860381ex99_1s9g1.jpg GRAPHIC 120257
  Complete submission text file 0001193125-24-171204.txt   4824137

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA spry-20240627.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE spry-20240627_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spry-20240627_pre.xml EX-101.PRE 11705
49 EXTRACTED XBRL INSTANCE DOCUMENT d860381d8k_htm.xml XML 3773
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 241081297
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)